Is iron gluconate really safer than iron dextran? [6]

Blood

Volumn 101, Issue 9, 2003, Pages 3756-3757

  Eichbaum, Quentin ^b   Foran, Stacy ^b   Dzik, Sunny ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FERRIC GLUCONATE; FERROUS GLUCONATE; IRON DEXTRAN; FERRIC ION;

ALLERGIC REACTION; ANAPHYLAXIS; DOSE CALCULATION; DRUG SAFETY; DRUG TOLERABILITY; DYSPNEA; FATALITY; HEADACHE; HUMAN; HYPERTENSION; LETTER; MUSCLE SPASM; PARENTERAL NUTRITION; PRIORITY JOURNAL; SHOCK; SIDE EFFECT; TACHYCARDIA; URTICARIA; VERTIGO; DRUG HYPERSENSITIVITY; HOSPITALIZATION; INCIDENCE; INTRAVENOUS DRUG ADMINISTRATION; RETROSPECTIVE STUDY; SAFETY; UNITED STATES;

BOSTON; DRUG HYPERSENSITIVITY; FERRIC COMPOUNDS; HUMANS; INCIDENCE; INFUSIONS, INTRAVENOUS; IRON-DEXTRAN COMPLEX; RETROSPECTIVE STUDIES; SAFETY; SEVERITY OF ILLNESS INDEX;

EID: 0038542810     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-02-0360     Document Type: Letter

References (7)

1. Hamstra RD, Block MH, Schokert AL. Intravenous iron dextran in clinical medicine. JAMA. 1980;243:1726-1731.
2. Andrews NC. Disorders of iron metabolism. N Engl J Med. 1999;341:1986-1995.
3. Faich G, Strobos J. Sodium ferric gluconate complex in sucrose: safer intravenous iron therapy than iron dextrans. Am J Kid Dis. 1999;33:464-470.
4. Burns DL, Pomposelli JJ. Toxicity of parenteral iron dextran therapy. Kidney Int Suppl. 1999;69:S119-S123.
5. Michael B, Coyne DW, Fishbane S, et al. Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextran. Kid Int. 2000;61:1830-1839.
6. Fishbane S, Kowalski, EA. Comparative safety of intravenous iron dextran, iron saccharate and sodium ferric gluconate. Semin Dial. 2000;13:381-384.
7. Schrand LM, Johnson SJ, Berkowski SS. New intravenous iron products: increasing safety at UIHC [letter]. P T News. 2001.